ZFC3H1 as an Indicator of Poor Prognosis in Hepatocellular Carcinoma: Bioinformatic Analysis and Experimental Verification.

Jiaxin Zhao Cheng Wang Rui Wu Zheyu Fang Rui Dong Jie Zhou Zhenhua Hu

Published in: Combinatorial chemistry & high throughput screening (2024)

ZFC3H1 is upregulated in HCC, promoting the proliferation and migration of liver cancer cells, impacting the prognosis of HCC patients and the effectiveness of immunotherapy. ZFC3H1 might serve as a therapeutic target and biomarker for HCC.

Keyphrases

poor prognosis
end stage renal disease
long non coding rna
ejection fraction
newly diagnosed
randomized controlled trial
chronic kidney disease
systematic review
peritoneal dialysis
prognostic factors
patient reported outcomes